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doi:10.1016/j.ejvs.2008.04.008Abstract Objectives: To evaluate an unsupervised home-based exercise programme for
physiological, functional, and quality of life impact in patients with symptomatic peripheral
arterial disease.
Design: Prospective cohort with exercise intervention.
Materials: Human performance laboratory with non-invasive haemodynamic assessment
facilities.
Methods: Forty-seven patients with symptomatic peripheral arterial disease (mean age
67.6 7 years, 33 males) participated in an unsupervised home-based exercise programme.
Heart rate (HR), ankle brachial blood pressure index (ABPI), leg blood flow (BF), and blood
lactate were measured before and after a graded treadmill walk at baseline and after the
12-week exercise programme. Maximum walking distance (MWD) during the treadmill walk
was measured at baseline and 12 weeks. Exercise compliance, functional parameters, and
quality of life (VascuQoL) were assessed by questionnaire.
Results: MWD, leg BF, and VascuQoL scores increased significantly, while resting HR, exercise
HR, and end of walk rate-pressure-product (RPP) decreased significantly after 12 weeks.
Exercise compliance was significantly correlated with increase in MWD (rZ 0.89, p< 0.001)
and QOL score improvement (rZ 0.61, p< 0.001).
Conclusions: This supported but unsupervised exercise programme generated improvements in
walking distance and leg blood flow without detectable increases in cardiorespiratory work.
Exercise compliance is related to MWD and VascuQoL score in a dose-response manner.
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320 A.J. Roberts et al.Introduction representing approximately 15% of clinic attendancesIt is established that exercise therapy has a central role in
management of peripheral arterial disease.1,2 Furthermore,
such treatment should comprise intermittent walking suffi-
cient to induce significant discomfort, carried out over
a period of at least several months.1,3 Although unsuper-
vised home-based exercise has found favour in a cardiac
rehabilitation setting,4e7 the relative merits of unsuper-
vised and institution-based exercise in peripheral arterial
disease is a subject of debate. Limited data suggests institu-
tion based therapy may be more efficacious than unsuper-
vised therapy.8,9 In a reflection of this evidence base, The
American College of Cardiology/American Heart Association
Practice Guidelines gives unsupervised exercise pro-
grammes in peripheral arterial disease a class IIb recom-
mendation, based on level-B evidence.10 However, the
notion that exercise training must be supervised should
not go unchallenged. Previously published data has demon-
strated that a home-based exercise programme can improve
pain-free walking distance without significant changes in
femoral blood flow, cardiac work, or oxygen debt.11 How-
ever, conventional indices of peripheral arterial disease
severity correlate poorly with other measurements of dis-
ease burden and health related quality of life.12 By incorpo-
rating data on exercise compliance, central and peripheral
vascular function, and health related quality of life, this
study enables an exploration of the interplay between these
variables in response to a 12-week programme of home-
based walking exercise for claudicants.
Materials and Methods
Subjects
Subjects were recruited from a consecutive series of
patients attending a vascular surgery clinic over a 13-
month period. Approximately 20% of these patients had
evidence of stenotic and/or aneurysmal aorto-iliac disease
and were not considered for recruitment, as exercise
training is considered to be of limited value in such
patients. Inclusion criteria were a clinical diagnosis of
peripheral arterial disease in individuals aged between 40
and 85, intermittent claudication of at least 6 months total
duration and 3 months without symptomatic deterioration,
and either an Ankle Brachial Pressure Index (ABPI) of <0.9
or lower limb arterial stenosis of >50% confirmed on
duplex ultrasound or angiography. Exclusion criteria were
vascular or neurovascular intervention for lower limb
symptoms, myocardial infarction, acute coronary syn-
drome, or clinical evidence of heart failure in the pre-
ceding 6 months, deep vein thrombosis within the
preceding 3 months, resting blood pressure >185/95,
inability to complete a treadmill walk test for reasons
other than claudication, coexisting advanced disease that
might limit survival or ability to comply with the pro-
gramme, and gross obesity (BMI> 30). Initial screening
identified 61 patients meeting inclusion criteria, but 11
of these were ineligible on grounds of exclusion criteria
(co-morbidity). Fifty patients with intermittent claudica-
tion due to lower limb peripheral arterial disease,during the study period, were invited to take part in the
study. Three of this cohort did not participate (2 devel-
oped co-morbidity between recruitment and study com-
mencement, and 1 patient declined involvement). All
subjects gave written informed consent. The South Chesh-
ire Research Ethics Committee approved this study.
Exercise programme
Before beginning the programme, each subject received
instruction regarding the exercise regime, which consisted
of at least one hour of walking every day, including rest
periods as necessary. Subjects were contacted by tele-
phone on a weekly basis in order to assess progress and
reiterate the recommended walking guidelines. Subjects
were instructed to complete exercise diaries in order to
improve accuracy of self-reported exercise duration.
Measured parameters
Subjects underwent a familiarisation session prior to any
measurements being taken. This involved practice in
treadmill walking and instruction regarding other investi-
gations that were to be carried out.
The baseline tests took place one week after the
familiarisation visit. Patients were rested for 30 minutes
prior to any tests. These involved administration of the
Vascular Quality of Life Survey (VascuQol),13 measurement
of height, weight, percentage body fat (Omron BF 305),
resting blood lactate, serum lipids, full blood count, coag-
ulation screen, pulse rate, right brachial blood pressure,
ankle blood pressure (dorsalis pedis and/or posterior tibial
in the most symptomatic leg), and calf blood flow by ve-
nous occlusion plethysmography (in the most symptomatic
leg) (PVL 50, SciMed, Bristol, UK). Subsequently, subjects
underwent graded incremental exercise testing on a motor-
ized treadmill using the Skinner-Gardner protocol14 (HP
Cosmos Pulsar, Germany). For this, speed was kept con-
stant at 2km/h and gradient was increased in 2% incre-
ments every 2 minutes to a maximum of 16%. The
treadmill test was terminated at the request of the sub-
ject, at which time the maximum walking distance was re-
corded. Heart rate was monitored constantly during
treadmill testing, and ABPI was recorded at maximum
walking distance. Repeat plethysmography was undertaken
immediately following blood pressure recordings, and
blood lactate was recorded at 1 minute and 6 minutes
post treadmill testing.
All subjects underwent repeat testing as above after 12
weeks. Tests were carried out at the same time of day on
each occasion, and subjects were asked to avoid caffeine
intake for 24 hours preceding each testing session.
A depiction of the study profile is given in Fig. 1.
Statistical analysis
Sample sizes were chosen for paired samples analysis based
on a hypothecated mean increase in walking distance of
50% between baseline and 12 weeks, with power of 0.8 and
alpha of 0.05. Parametric quantitative variables are
1 declined 2 excluded due to
comorbidity
50 subjects initially eligible
47 subjects recruited
Instruction on exercise
Familiarisation visit
Testing at rest: VascuQol score, ABPI, calf blood flow, pulse
rate, lactate and other blood tests
Testing at end of treadmill test: ABPI, calf blood flow, pulse
rate, lactate (1 and 6 minutes)
Maximum Walk Distance on Treadmill
12 week home exercise programme
with weekly telephone advice and
exercise diary
Repeat
testing
at
week
12
61 patients met inclusion criteria
11 excluded on
exclusion criteria
Figure 1 Study profile.
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parametric quantitative variables are expressed as medians
with inter-quartile ranges (iqr). Comparisons between
paired parametric quantitative variables were made using
paired samples T-testing, while non-parametric data
comparisons were made with Wilcoxon signed rank testing.
Correlations between quantitative nonparametric data
were assessed using the Spearman test. The threshold for
statistical significance is 0.05 (2-tailed).Table 1 Baseline and week 12 measurements
Baseli
Body mass index (kg/m2) 26.6
Resting Heart Rate (per minute) 89.3
Exercise Heart Rate (per minute) 118.5
Resting systolic Blood Pressure (mmHg) 164 (i
Exercise Systolic Blood Pressure (mmHg) 182 (i
Resting Rate Pressure Product (mmHg / minute) 22035
Resting Ankle Brachial Pressure Index 0.8 (iq
Exercise Ankle Brachial Pressure Index 0.5 (iq
Resting Blood Flow Index 0.70 (
Exercise Blood Flow Index 1.23 (
Resting Lactate 1.9 (iq
1 Minute Post Exercise Lactate 2.8 (iq
6 Minute Post Exercise Lactate 2.5 (iqResults
Two subjects were excluded on grounds of comorbidity. One
subject declined involvement in the study. The final pop-
ulation consisted of 47 subjects (33 males) with a mean age
of 67.7 7 years. Body mass index was 26.5 4.2 kg/m2 at
recruitment and did not change during the study. Resting An-
kle-Brachial Pressure Index (APBI) was a median of 0.77 at
recruitment and remained unchanged. Six subjects admit-
ted to cigarette smoking (current or within previous month).
One subject quit smoking during the study period.
Maximum walking distance
There was an increase in maximum walking distance of
76.2% between baseline and 12 weeks (126 m at baseline,
222 m at week-12, p< 0.001). Four subjects experienced
a slight drop in walking distance, while others all increased
their distance (Table 1).
Heart rates and rate pressure product
Resting heart rates fell from 89.3 18.9 per minute at
baseline to 82.8 14.9 per minute at 12 weeks
(PZ 0.001) (Table 1). Exercise heart rates at 2 minutes
also fell between these times from a median of 118.8 per
minute to 102.2 per minute (p< 0.001). Rate-Pressure-
Product (RPP) was lower at rest and at maximum walking
distance after the 12-week programme. Mean resting RPP
fell from 14545 to 12795 mmHg/min (p< 0.001), while
mean exercise RPP fell from 22035 to 17502 (p< 0.001).
This reduction was driven by a combination of heart rate
fall and reduction in systolic blood pressure (see Table1).
Diastolic pressures
Brachial mean diastolic blood pressure at rest was
88.2 14.1 at baseline and 90.4 13.1 at 12 weeks
(pZ 0.32). Mean peak exercise BP was 93.4 14.8 at base-
line and 89.3 11.4 at 12 weeks (pZ 0.08).ne Week-12 p
4.2 26.7 4.3 0.8
18.9 82.8 14.9 0.001
 21.2 102.2 16.5 <0.001
qr 147e177) 152 (iqr 142e165) 0.07
qr 172e200) 173 (iqr 161e182) <0.001
 4048 17502 3541 <0.001
r 0.63e1.0) 0.72 (iqr 0.65e0.90) 0.24
r 0.3e0.60) 0.5 (iqr 0.39e0.70) 0.12
iqr 0.41e0.81) 0.77 (iqr 0.60e0.98) <0.001
iqr 0.78e1.91) 1.57 (iqr 1.18e2.13) <0.001
r 1.3e2.4) 2.1 (iqr 1.6e2.5) 0.78
r 2.3e3.5) 2.8 (iqr 2.2e3.3) 0.075
r 2.0e2.9) 2.5 (iqr 1.8e3.3) 0.9
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Figure 2 Exercise compliance and achieved Maximum
Walking Distance.
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322 A.J. Roberts et al.Peripheral haemodynamics and lactate levels
There were no significant changes between baseline and
week-12 in ABPI readings, either at rest or immediately
after achieving maximum walk (see Table 1). However, both
resting and post treadmill exercise plethysmographic calf
muscle blood flow indices did change. There was an
increase in blood flow index at rest from a median of 0.70
to 0.77, p< 0.001, and after maximum walk from 1.28 to
1.57, p< 0.001 (Table 1). There were no significant changes
in blood lactate levels at either 1 or 6 minutes post tread-
mill exercise between baseline and 12-week follow up
(see Table 1).
Vascular quality of life score
The vascular quality of life score (VascuQol) has domains
for activities, symptoms, pain, emotional effects, and
social functioning. There were statically significant
improvements in all except the social function domain
between baseline and 12-weeks follow up. Total VascuQol
score increased significantly from a median of 76 to 93
(p< 0.001). Total score increased by 22.4%, while pain
score improved by 41.6% (see Table 2).
Exercise compliance
Median self reported compliance with walking exercise in
this cohort was 5 hours per week (iqr 3 to 7 hours).
Maximum walking distance and VascuQuol results are
displayed against different levels of exercise compliance
in Figs. 2 and 3. It is noteworthy that exercise compliance
correlated with both percentage change in maximum walk-
ing distance and total VascuQoL score (Spearman’s rho
0.89, p< 0.001 and 0.61, P< 0.001 respectively). There
was no significant correlation between exercise compliance
and the cardiovascular variables.
Discussion
This study shows that an unsupervised but supported
walking exercise programme can improve maximum walk-
ing distance, leg blood flow, and all domains of a vascular
quality of life assessment except social function. Further-
more, improved leg blood flow occurred without any
significant change in Ankle-Brachial Pressure Index while
being accompanied by a reduction in cardiac work as
measured by Rate Pressure Product.
There are a number of conclusions that can be drawn
from these findings. The first notable conclusion is thatTable 2 VascuQol scores
Baseline Week-12 p
Activity 19 (iqr 18e21) 24 (iqr 20e32) <0.001
Symptoms 13 (iqr 10e16) 16 (iqr 12e21) <0.001
Pain 12 (iqr 10e14) 17 (iqr 13e20) <0.001
Emotional 25 (iqr 23e30) 30 (iqr 25e32) <0.001
Social 6 (iqr 4e7) 6 (iqr 5e8) 0.2
Total 76 (iqr 70e81) 93 (iqr 78e105) <0.001a home-based exercise programme has again been shown to
confer measurable benefits to patients with symptomatic
peripheral arterial disease. Notwithstanding the fact that
supervised exercise programmes probably effect a greater
improvement in such patients,8,9 the benefits of home-
based programmes are clear. Indeed the greatest benefit
for the greatest number of patients at any given cost should
be the guiding tenet when planning healthcare, and it is
likely that home based programmes are less expensive to
resource than supervised institution-based schemes.
Despite costs of support, which involves baseline exercise1 2 3 4
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An Unsupervised Exercise Programme for Claudicants 323‘‘prescription’’ and subsequent weekly telephone contact
and encouragement, cost benefits of programmes devolved
away from institutions to the home are easy to see.
Furthermore, compliance with exercise may be more likely
in the convenience of a home setting. This data provides
more evidence on which prescribed and supported but
unsupervised walking based exercise can be implemented
for patients with intermittent claudication, especially if
costs of institution-based programmes is prohibitive.
These results provide an insight into the mechanism of
improvement in walking distance and ultimately quality of
life in claudicants. The fact that leg blood flow improved
without changes in ankle brachial pressure index and
simultaneously with reductions in cardiac work suggests
peripheral adaptation rather than enhanced cardiac func-
tion as the underlying mechanism. The exact mechanism of
peripheral adaptation is unclear from published data.15 In
particular, the relative importance of increased blood
inflow versus local redistribution of existing blood flow is
unresolved. The most likely phenomenon by which blood
flow in our study increased is collateralisation on a small
vessel scale within calf musculature. This would not neces-
sarily affect the dorsalis pedis and posterior tibial artery
systolic pressures, on account of redistribution rather
than an absolute increase. Additional mechanisms could
also be at play, however. It is plausible that locomotor effi-
ciency improved in some patients as a result of their walk-
ing exercises, although gait analysis was not part of the
present study. Another possible mechanism by which
improved blood flow might occur is reduced peripheral vas-
cular resistance. Peak exercise diastolic blood pressures did
drop slightly at 12 weeks, in keeping with a reduction in
resistance. The absolute level of this reduction was small,
however.
The absence of any significant changes in lactate release
into the venous system at 1 or 6 minutes post treadmill
walks is compatible with additional metabolic adaptation
on a cellular level. However, a different study design might
have allowed observation of different lactate profiles to
those we describe. It might have been more informative to
draw blood for lactate at the initial peak walking distance
and at the 12-week peak walking distance. Thus, lactate
comparisons for the same stage of each walk could be
made. Unfortunately, the practical constraints of carrying
out blood sampling at these precise times as well as
adhering to other protocol requirements were prohibitive.
The co-existence of peripheral and coronary artery
disease, and the associated excess cardiac mortality in
claudicants, are well known consequences of generalized
atherosclerosis.2,16e20 A reassuring finding in this study is
that increased exercise test physical workload occurred
despite an apparent reduction in Rate-Pressure Product,
and therefore at a lower cardiac workload. Athough Rate-
Pressure Product itself is not a specific outcome measure
in peripheral arterial disease, the changes could be patho-
physiologically relevant. Indeed, a theoretical beneficial
effect of this, especially pertinent in the home exercise
setting, is that the risk of exercise related cardiac arrhyth-
mia may reduce for a given level of physical work.
Smoking cessation can be expected to have an impact on
inetermittent claudication as well as prognosis. Only six of
this cohort were smokers at the outset, and one subjectquit smoking during the study. Such small numbers do not
allow meaningful quantitative analysis, and we have pur-
posefully avoided interpreting this data in relation to
smoking cessation.
While of relevance to pathophysiology, specific
measurements such as lactate and leg blood flow do not
necessarily correlate with how a patient feels. Increasingly,
disease specific health related quality of life scoring tools
are finding a role in quantifying both disease severity and
treatment effects. The VascuQoL score was developed in
the knowledge that peripheral arterial disease had numer-
ous and hitherto non-quantified consequences for daily
living.13 It has been validated against other indices of
disease and is recommended as ‘‘the most disease respon-
sive specific instrument for evaluating quality of life
changes in intermittent claudication’’, although the caveat
that no single scoring system is yet ideal should be acknowl-
edged.21 The fact that patients experienced statistically
significant improvements in all but one VascuQol domain
is very reassuring and should offer another pillar of support
for home-based exercise programmes. The lack of signifi-
cant improvement in social function is likely to be due to
the short timescale of the study. Sustained physical and
emotional improvements over a longer time period are
likely to result in better social function scores. It is estab-
lished that walking is beneficial in peripheral arterial disea-
se,1e3,22 and the rate of symptomatic decline has been
shown to reduce in those with greater self-reported exer-
cise frequency.23 This is, to our knowledge, the first study
to demonstrate a dose response relationship between exer-
cise compliance and both maximum walking distance and
VascuQol score following an unsupervised exercise scheme.
The correlation between hours per week spent walking and
measured walking improvement is particularly strong.
Taken together, these findings mean that, within the limits
of exercise compliance that we have tested, patients in
home-based unsupervised but supported programmes can
be given a clear and evidence based message that ‘‘the
more you walk, the more you will be able to walk, and
the better you will function and feel’’.
Limitations
1 There was no control group for this study. The
suggested link between the exercise programme and
improvements we documented could theoretically be
associative rather than causative. However, the dose-
response effect strengthens the claim for causation.
2 The study is limited to 12 weeks follow up.
3 Recent instability in peripheral or coronary circulatory
status were exclusion criteria. The programmes’ safety
and benefits cannot be said to apply to an unselected
cohort of patients with peripheral arterial disease,
a proportion of whom may have had such comorbidity.
Furthermore, patients with supra-inguinal arterial
disease were not considered for this study, and the
conclusions cannot be extrapolated to such a group.
4 The exercise programme is not supervised in the
traditional sense of an institution-based scheme.
However, there was a remote type of supervision in
the form of a prescribed exercise regime and regular
telephone contact. The benefits we observed might
324 A.J. Roberts et al.not occur in programmes devoid of any healthcare
contact.
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